ELVN Overview
Upcoming Projects (ELVN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ELVN)
-
Discussing the SoC for Chronic Myeloid Leukemia (CML), how Scemblix is currently used, and how ELVN-001 from Enliven Therapeutics might slot into the treatment algorithm.
Tickers: ELVN, NVS
Executed On: Sep 08, 2025 at 02:00 PM EDT -
Looking into ELVN-001 for the treatment of CML and its Phase 1 clinical trial data.
Ticker: ELVN
Executed On: Dec 18, 2024 at 01:30 PM EST -
A second look: Discussing Enliven Therapeutics' ELVN-001 and Its Clinical Implications in Chronic Myeloid Leukemia (CML)
Ticker: ELVN
Executed On: May 06, 2024 at 01:30 PM EDT -
Discussing Enliven Therapeutics' ELVN-001 and Its Clinical Implications in Chronic Myeloid Leukemia (CML)
Ticker: ELVN
Executed On: Apr 18, 2024 at 03:00 PM EDT
Upcoming & Overdue Catalysts (ELVN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (ELVN)
-
Don’t see a strategic initiative related to the company you care about? Create your own!